Serena Williams’ return fuels record Wimbledon ratings for ESPN

Serena Williams, Andy Murray and the biggest storylines at Wimbledon this year

Two of the sport’s greats are back at SW19 this year

BBC pundit makes Serena Williams claim after Wimbledon defeat

BBC pundit makes Serena Williams claim after Wimbledon defeat

Serena Williams Ignites Debate Over Athletes Taking GLP-1s

NurPhoto / Getty ImagesSerena Williams’ triumphant return to competitive tennis has reignited a surprisingly thorny debate that stretches far beyond the court: Are GLP-1 weight-loss drugs giving athletes an unfair edge?The 23-time Grand Slam champion returned to the court earlier this month at the Queen’s Club Championship for her first doubles competition in nearly four years, teaming up with 19-year-old Canadian doubles partner Victoria Mboko for a convincing win.The 44-year-old’s performance immediately drew attention online, with some critics questioning whether her public use of the weight-loss drug tirzepatide could provide an athletic advantage.Read more at The Daily Beast.

Wimbledon is back today – here are nine storylines to get you up to speed

Teenage contenders, prize money protests, predictions, Serena's return, and a last dance for Djokovic? Here is your Wimbledon refresher

Serena Williams Is Coming Back As A Wild Card At Wimbledon

After a few months of cheeky silence and misdirection, plus an experiment on the doubles court, Serena Williams is completing her comeback to professional tennis. The 44-year-old has accepted a wild card into the singles main draw at Wimbledon, which begins next week, causing the traditionally stodgy tournament to post heatedly about the occasion. Williams retired from competition after a third-round appearance at the 2022 U.S. Open. Her first-round match at Wimbledon will mark her first professional singles match since that day. She won the grass-court major seven times, most recently in 2016. In her last appearance in 2022, she lost in the first round. When Williams reentered the anti-doping testing pool at the end of 2025, I thought we were about to witness an extremely effortful marketing campaign for the telehealth company her husband Alexis Ohanian invests in, and the GLP-1 drugs it prescribes. Since her original retirement, she has appeared regularly in ads for the company, and credited the drugs with losing 34 pounds before her return to competition.